← Back to Search

Other

Continuous Theta Burst Stimulation for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Sarah H Lisanby, M.D.
Research Sponsored by National Institute of Mental Health (NIMH)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately pre and post rtms
Awards & highlights

Study Summary

This trial is testing whether or not repetitive transcranial magnetic stimulation (rTMS) can help people with autism spectrum disorder (ASD).

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately pre and post rtms
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately pre and post rtms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
DTI
MRS
fcMRI
Secondary outcome measures
MEG
Neuropsychological Assessments

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active cTBSExperimental Treatment1 Intervention
This intervention involves active repetitive magnetic stimulation. The coil emits a magnetic field
Group II: Sham cTBSPlacebo Group1 Intervention
This intervention involves sham (placebo) repetitive transcranial magnetic stimulation. The coil is blinded, but does not emit any magnetic field
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous Theta Burst Stimulation
2020
N/A
~30

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)Lead Sponsor
2,785 Previous Clinical Trials
2,689,650 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,246 Patients Enrolled for Autism Spectrum Disorder
Sarah H Lisanby, M.D.Principal InvestigatorNational Institute of Mental Health (NIMH)
5 Previous Clinical Trials
348 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Missouri
Other
North Carolina
Pennsylvania
How old are they?
< 18
18 - 65
What site did they apply to?
National Institutes of Health Clinical Center
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Phone Call
Email
Most responsive sites:
  1. National Institutes of Health Clinical Center: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
2021. "Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04798274.
~6 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top